Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| SMO-H52P3 | Human | Human SMO Full Length Protein (VLP) |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Sonidegib Diphosphate | LDE-225; NVP-LDE-225 | Approved | Novartis Pharma Ag | Odomzo, 奥昔朵 | United States | Carcinoma, Basal Cell | Sun Pharmaceutical Industries Ltd | 2015-07-24 | Colorectal Neoplasms; Small Cell Lung Carcinoma; Glioblastoma; Myeloproliferative Disorders; Blood Platelet Disorders; Multiple Myeloma; Basal Cell Nevus Syndrome; Prostatic Neoplasms; Breast Neoplasms; Neuroblastoma; Thrombocytosis; Primary Myelofibrosis; Pancreatic Neoplasms; Astrocytoma; Hepatic Insufficiency; Bone Marrow Diseases; Carcinoma, Pancreatic Ductal; Leukemia, Myeloid, Acute; Lung Neoplasms; Glioma; Carcinoma, Hepatocellular; Thrombocythemia, Essential; Adenocarcinoma; Carcinoma, Basal Cell; Ovarian Neoplasms; Solid tumours; Hematologic Neoplasms; Rhabdomyosarcoma; Leukemia; Medulloblastoma; Blood Coagulation Disorders; Hemorrhagic Disorders; Hematologic Diseases; Leukemia, Myelogenous, Chronic; Bone Marrow Neoplasms; Esophageal Neoplasms; Polycythemia Vera; Hepatoblastoma; Stomach Neoplasms; Triple Negative Breast Neoplasms; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Graft vs Host Disease; Fibrosis; Skin Neoplasms | Details |
| Glasdegib | PF-04; PF-4449913; PF-04449913 | Approved | Pfizer Inc | Daurismo | United States | Leukemia, Myeloid, Acute | Pfizer Inc | 2018-11-21 | Hematologic Neoplasms; Solid tumours; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Graft vs Host Disease; Kidney Diseases; Neoplasms; Hepatic Insufficiency; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Fasciitis | Details |
| Vismodegib | R-3616; RG-3616; GDC-0449 | Approved | Genentech Inc, F. Hoffmann-La Roche Ltd | Erivedge | United States | Carcinoma, Basal Cell | Genentech Inc | 2012-01-30 | Gastrointestinal Stromal Tumors; Liposarcoma; Chondrosarcoma, Clear Cell; Basal Cell Nevus Syndrome; Neurofibrosarcoma; Sarcoma; Breast Neoplasms; Osteosarcoma; Sarcoma, Ewing; Prostatic Neoplasms; Brain Neoplasms; Chondrosarcoma, Extraskeletal Myxoid; Gliosarcoma; Colorectal Neoplasms; Sarcoma, Synovial; Lymphoma, Non-Hodgkin; Lymphoma; Carcinoma, Pancreatic Ductal; Leukemia, Myeloid, Acute; Uterine Neoplasms; Chondrosarcoma, Mesenchymal; Leukemia, Lymphocytic, Chronic, B-Cell; Central Nervous System Lymphoma; Sarcoma, Kaposi; Neuroectodermal Tumors, Primitive, Peripheral; Adenocarcinoma; Hemangioendothelioma, Epithelioid; Stomach Neoplasms; Leiomyosarcoma; Rhabdomyosarcoma; Medulloblastoma; Ovarian Neoplasms; Chondrosarcoma; Fibrosarcoma; Hematologic Neoplasms; Carcinoma, Basal Cell; Hemangiosarcoma; Desmoplastic Small Round Cell Tumor; Mesenchymoma; Carcinoma, Renal Cell; Esophageal Neoplasms; Solid tumours; Odontogenic Cyst, Calcifying; Graft vs Host Disease; Skin Neoplasms; Lymphoma, Large B-Cell, Diffus | Details |
| Sonidegib Diphosphate | LDE-225; NVP-LDE-225 | Approved | Novartis Pharma Ag | Odomzo, 奥昔朵 | United States | Carcinoma, Basal Cell | Sun Pharmaceutical Industries Ltd | 2015-07-24 | Colorectal Neoplasms; Small Cell Lung Carcinoma; Glioblastoma; Myeloproliferative Disorders; Blood Platelet Disorders; Multiple Myeloma; Basal Cell Nevus Syndrome; Prostatic Neoplasms; Breast Neoplasms; Neuroblastoma; Thrombocytosis; Primary Myelofibrosis; Pancreatic Neoplasms; Astrocytoma; Hepatic Insufficiency; Bone Marrow Diseases; Carcinoma, Pancreatic Ductal; Leukemia, Myeloid, Acute; Lung Neoplasms; Glioma; Carcinoma, Hepatocellular; Thrombocythemia, Essential; Adenocarcinoma; Carcinoma, Basal Cell; Ovarian Neoplasms; Solid tumours; Hematologic Neoplasms; Rhabdomyosarcoma; Leukemia; Medulloblastoma; Blood Coagulation Disorders; Hemorrhagic Disorders; Hematologic Diseases; Leukemia, Myelogenous, Chronic; Bone Marrow Neoplasms; Esophageal Neoplasms; Polycythemia Vera; Hepatoblastoma; Stomach Neoplasms; Triple Negative Breast Neoplasms; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Graft vs Host Disease; Fibrosis; Skin Neoplasms | Details |
| Glasdegib | PF-04; PF-4449913; PF-04449913 | Approved | Pfizer Inc | Daurismo | United States | Leukemia, Myeloid, Acute | Pfizer Inc | 2018-11-21 | Hematologic Neoplasms; Solid tumours; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Graft vs Host Disease; Kidney Diseases; Neoplasms; Hepatic Insufficiency; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Fasciitis | Details |
| Vismodegib | R-3616; RG-3616; GDC-0449 | Approved | Genentech Inc, F. Hoffmann-La Roche Ltd | Erivedge | United States | Carcinoma, Basal Cell | Genentech Inc | 2012-01-30 | Gastrointestinal Stromal Tumors; Liposarcoma; Chondrosarcoma, Clear Cell; Basal Cell Nevus Syndrome; Neurofibrosarcoma; Sarcoma; Breast Neoplasms; Osteosarcoma; Sarcoma, Ewing; Prostatic Neoplasms; Brain Neoplasms; Chondrosarcoma, Extraskeletal Myxoid; Gliosarcoma; Colorectal Neoplasms; Sarcoma, Synovial; Lymphoma, Non-Hodgkin; Lymphoma; Carcinoma, Pancreatic Ductal; Leukemia, Myeloid, Acute; Uterine Neoplasms; Chondrosarcoma, Mesenchymal; Leukemia, Lymphocytic, Chronic, B-Cell; Central Nervous System Lymphoma; Sarcoma, Kaposi; Neuroectodermal Tumors, Primitive, Peripheral; Adenocarcinoma; Hemangioendothelioma, Epithelioid; Stomach Neoplasms; Leiomyosarcoma; Rhabdomyosarcoma; Medulloblastoma; Ovarian Neoplasms; Chondrosarcoma; Fibrosarcoma; Hematologic Neoplasms; Carcinoma, Basal Cell; Hemangiosarcoma; Desmoplastic Small Round Cell Tumor; Mesenchymoma; Carcinoma, Renal Cell; Esophageal Neoplasms; Solid tumours; Odontogenic Cyst, Calcifying; Graft vs Host Disease; Skin Neoplasms; Lymphoma, Large B-Cell, Diffus | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Patidegib | SGT-610; BBP-009; FIN-5; IPI-926 | Phase 3 Clinical | Infinity Pharmaceuticals Inc | Chondrosarcoma; Head and Neck Neoplasms; Carcinoma, Basal Cell; Neoplasms; Pancreatic Neoplasms; Basal Cell Nevus Syndrome; Primary Myelofibrosis; Adenocarcinoma | Details |
| Taladegib | RXDX-109; ENV-IPF-101; ENV-ONC-101; LY-2940680; ENV-101 | Phase 2 Clinical | Eli Lilly And Company | Solid tumours; Medulloblastoma; Rhabdomyosarcoma; Idiopathic Pulmonary Fibrosis; Colonic Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Cholangiocarcinoma; Sarcoma; Breast Neoplasms; Neoplasm Metastasis | Details |
| GT-1708F | GT-1708; GT1708F; GT-1708F | Phase 2 Clinical | Suzhou Koshine Biomedica Inc | Hematologic Neoplasms; Solid tumours; Idiopathic Pulmonary Fibrosis | Details |
| Cipromedegib | SHR-1539 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd | Solid tumours | Details |
| ZSP-1602 | ZSP-1602 | Phase 1 Clinical | Guangdong Zhongsheng Pharmaceutical Co Ltd | Medulloblastoma; Carcinoma; Carcinoma, Basal Cell; Small Cell Lung Carcinoma; Neoplasms; Pancreatic Neoplasms; Glioblastoma; Neuroendocrine Tumors; Glioma; Adenocarcinoma | Details |
| Patidegib | SGT-610; BBP-009; FIN-5; IPI-926 | Phase 3 Clinical | Infinity Pharmaceuticals Inc | Chondrosarcoma; Head and Neck Neoplasms; Carcinoma, Basal Cell; Neoplasms; Pancreatic Neoplasms; Basal Cell Nevus Syndrome; Primary Myelofibrosis; Adenocarcinoma | Details |
| Taladegib | RXDX-109; ENV-IPF-101; ENV-ONC-101; LY-2940680; ENV-101 | Phase 2 Clinical | Eli Lilly And Company | Solid tumours; Medulloblastoma; Rhabdomyosarcoma; Idiopathic Pulmonary Fibrosis; Colonic Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Cholangiocarcinoma; Sarcoma; Breast Neoplasms; Neoplasm Metastasis | Details |
| GT-1708F | GT-1708; GT1708F; GT-1708F | Phase 2 Clinical | Suzhou Koshine Biomedica Inc | Hematologic Neoplasms; Solid tumours; Idiopathic Pulmonary Fibrosis | Details |
| Cipromedegib | SHR-1539 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd | Solid tumours | Details |
| ZSP-1602 | ZSP-1602 | Phase 1 Clinical | Guangdong Zhongsheng Pharmaceutical Co Ltd | Medulloblastoma; Carcinoma; Carcinoma, Basal Cell; Small Cell Lung Carcinoma; Neoplasms; Pancreatic Neoplasms; Glioblastoma; Neuroendocrine Tumors; Glioma; Adenocarcinoma | Details |
This web search service is supported by Google Inc.
A-Z
